Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19?
Hyaluronidase is currently not included into Russian or foreign guidelines on the treatment of acute respiratory distress-syndrome in patients with COVID-19, and such treatment is not supported by evidence of clinical effectiveness. Hyaluronidase can only be used for COVID-19 within clinical trials.
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
Izdatelstvo OKI
2020-10-01
|
| Series: | Качественная клиническая практика |
| Assuntos: | |
| Acceso en liña: | https://www.clinvest.ru/jour/article/view/522 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|